AstraZeneca PLC - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AZN Nasdaq 2830 www.astrazeneca.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AstraZeneca PLC

AstraZeneca (AZN) Announces Strategic Research Collaboration with CSPC Pharmaceuticals - Jun 30th, 2025 9:31 am
Rakovina Therapeutics Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025 - Jun 30th, 2025 1:00 am
Evotec (EVO) Joins NURTuRE-AKI Consortium to Advance Kidney Injury Drug Discovery - Jun 29th, 2025 1:03 am
AstraZeneca (AZN) Scores FDA Approval for Datroway, First TROP2 ADC for Lung Cancer - Jun 28th, 2025 3:41 am
Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium - Jun 27th, 2025 4:00 pm
3 UK Stocks That May Be Trading Below Their Estimated Value In June 2025 - Jun 27th, 2025 12:37 am
Why AstraZeneca risks Trump’s wrath with bet on China - Jun 27th, 2025 12:00 am
Trump Vows To Cut 'The Best Deal' On Drug Prices. What To Expect. - Jun 26th, 2025 8:15 am
Is Astrazeneca (AZN) a Buy as Wall Street Analysts Look Optimistic? - Jun 26th, 2025 7:30 am
Ephicacy Appoints Névine Zariffa to Its Board of Directors - Jun 26th, 2025 7:00 am
UK's June 2025 Stock Picks Estimated Below Intrinsic Value - Jun 26th, 2025 12:39 am
IonQ (NYSE:IONQ) Achieves Quantum Leap In Simulating Fundamental Physics With New Quantum Technique - Jun 25th, 2025 12:05 pm
AstraZeneca (LSE:AZN) Gains FDA Approval For Datroway In Treating Advanced Lung Cancer - Jun 25th, 2025 11:50 am
AstraZeneca and Daiichi Sankyo Treatment Wins First of Its Kind FDA Blessing to Treat Lung Cancer - Jun 25th, 2025 4:30 am
AstraZeneca Presents Positive Phase I/II Data for Surovatamig in B-cell ALL at EHA 2025 - Jun 25th, 2025 2:09 am
Human Magic Acquires TapIn to Pioneer the Future of Work - Jun 25th, 2025 2:00 am
Here's Why Astrazeneca (AZN) is a Strong Growth Stock - Jun 24th, 2025 7:45 am
FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer - Jun 24th, 2025 7:04 am
DATROWAY® approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer - Jun 24th, 2025 5:00 am
FDA approves AstraZeneca and Daiichi Sankyo’s Datroway for NSCLC - Jun 24th, 2025 3:39 am